Engineers Gate Manager’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67K Sell
12,342
-50,452
-80% -$212K ﹤0.01% 2110
2026
Q1
$193K Buy
62,794
+47,365
+307% +$145K ﹤0.01% 1919
2025
Q4
$54.9K Buy
+15,429
New +$57.2K ﹤0.01% 1969

Other funds holding STLN

Engineers Gate Manager's STLN Position: Q2 2026 in Review

Engineers Gate Manager reduced its Starling Oncology (STLN) stake by 80% in Q2 2026, selling an estimated $212K and leaving 12,342 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Engineers Gate Manager first reported a position in STLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $193K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Engineers Gate Manager held 12,342 shares of Starling Oncology worth $67K as of Q2 2026.
  • Engineers Gate Manager sold 50,452 Starling Oncology shares in Q2 2026, an estimated $212K.
  • Starling Oncology made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2110 holding.
  • Engineers Gate Manager first reported a position in Starling Oncology in Q4 2025 and has held it in 3 quarters since.
  • Engineers Gate Manager's Starling Oncology position peaked at $193K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.